Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
The purpose of this research study is to determine whether and when patients with human papilloma virus positive squamous cell cancer of the oropharynx treated with radiation and chemotherapy clear their human papilloma virus infection.
Carcinoma, Squamous Cell|Head and Neck Neoplasms|Oropharyngeal Neoplasms
OTHER: Assessment of Oral HPV Infection
Proportion of patients with HPV-positive OPSCC undergoing CRT who are clear of their oral HPV infection at each time-point, 2 years post-CRT of last enrolled patient
Time to HPV clearance for patients with HPV-positive OPSCC undergoing CRT, 2 years post-CRT of last enrolled patient|Number of aneuploidy cells as measured by FISH (Florescent in-situ hybridization) and the mRNA copy number for HPV E6 and HPV E7 at each time-point, 2 years post-CRT of last enrolled patient|Clinical outcomes of interest (local control, loco-regional control, distant metastasis-free survival, and overall survival (OS)) in patients with HPV-positive OPSCC undergoing CRT, 2 years post-CRT of last enrolled patient
The purpose of this research study is to determine whether and when patients with human papilloma virus positive squamous cell cancer of the oropharynx treated with radiation and chemotherapy clear their human papilloma virus infection.